PMID: 3744569Jan 1, 1986Paper

Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide

International Archives of Occupational and Environmental Health
C T EveloP T Henderson

Abstract

Urine of twenty hospital workers was monitored for the excretion of the cytostatic drug cyclophosphamide using GC-MSD. The drug was found to be present above the detection limit of 0.5 microgram/24 h urine in five cases. A clear relationship between cyclophosphamide handling and the detectability of excretion existed. This method developed can be of use for biological monitoring studies directed toward the finding of exposure hazards.

References

Oct 1, 1974·Journal of Pharmaceutical Sciences·C PantarottoA Frigerio
Jan 28, 1984·Lancet·M HirstD F White
Oct 12, 1984·Journal of Chromatography·C Lartigue-MatteiJ A Berger
Jan 1, 1982·International Archives of Occupational and Environmental Health·R P BosP T Henderson
Jul 11, 1980·Journal of Chromatography·N van den Bosch, D de Vos
Jul 1, 1981·Cancer Treatment Reports·H WaksvikA Brøgger

❮ Previous
Next ❯

Citations

Dec 14, 1990·Pharmaceutisch Weekblad. Scientific Edition·G P KaijserJ H Beijnen
Dec 11, 2007·International Archives of Occupational and Environmental Health·M HedmerB A G Jönsson
Apr 25, 2012·International Archives of Occupational and Environmental Health·Laetitia Minh Mai LêEric Caudron
May 14, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Roberta TurciClaudio Minoia
Jul 1, 1996·Archives of Environmental Health·R M MaderH Rainer
Sep 3, 2002·Occupational and Environmental Medicine·E ZieglerP J Baxter
Feb 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·P J SessinkR P Bos
Jan 1, 1995·International Archives of Occupational and Environmental Health·P J SessinkR P Bos
Feb 17, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Paul J M SessinkTimothy G Tyler
Feb 8, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Bertrand FavierFrancesco Giammarile
Feb 26, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Paul Jm SessinkNassima Kassoul
Oct 13, 2012·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Michiko YukiPaul J M Sessink
Mar 9, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Pierre E WallemacqBertrand Favier
Sep 9, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Bruce R HarrisonMichael R Bing
Jul 13, 2005·Journal of Occupational and Environmental Medicine·Melissa A McDiarmid, Marian Condon
Jan 1, 1988·International Journal of Clinical Monitoring and Computing·K U Josten
Jan 1, 1997·Reviews on Environmental Health·R P Bos, P J Sessink
Jan 21, 2014·Journal of Occupational and Environmental Hygiene·Carl M MareshWilliam J Kraemer
Apr 27, 2016·Journal of Occupational and Environmental Hygiene·P A SchulteG R Wagner
May 23, 2021·International Archives of Occupational and Environmental Health·Antoine VillaMireille Canal-Raffin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved